ArticleDermatology and therapy2024

Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment.

Chun-Xia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.